UI Pharmaceuticals (UIP) is the largest and most experienced university-affiliated FDA-registered pharmaceutical manufacturing facility in the United States, operated by the University of Iowa. They offer comprehensive drug product CDMO services from formulation development through commercialization. In 2023, they launched a new 16,000 sq ft sterile processing facility with fill lines. They serve pharmaceutical, biotech, pediatrics, oncology, and research organizations worldwide.
University-affiliated CDMO, early-stage drug development, formulation to commercialization, sterile processing, pediatric formulations, orphan drug development
1 site worldwide
Involvement in 6 clinical trials
No reviews available yet.
No documents available.